New Jersey research universities – including top-ranked Princeton University and Rutgers, the State University of New Jersey – have a long history of supporting the research needs of the private sector.
Rutgers, the State University of New Jersey
Established in 1766, Rutgers, The State University of New Jersey, is America’s 8th oldest institution of higher learning and one of the nation’s premier public research universities. Its New Brunswick location is the only public institution in New Jersey represented in the prestigious Association of American Universities. Rutgers also is a member of the Big Ten Conference and its academic counterpart, the Big Ten Academic Alliance – a consortium of 14 world-class research universities.
The University’s externally-sponsored research grants and contracts in FY16 totaled $637.9 million, which was 4.1% greater than the prior year. Federal funding for Rutgers research was approximately $335 million in FY16. Research expenditures now exceed $628.6 million annually, which ranks Rutgers among the top 20 public universities in the nation for total R&D funding.
One of Rutgers’ highest priorities is expanding collaboration and partnerships with industry. The University launched a business portal which offers access to four key areas – research, technology licensing, professional development and recruiting. The University is investing in research, facilities, and equipment that will drive innovation in the private sector. Rutgers’ School of Engineering is developing cutting-edge techniques in continuous manufacturing for pharmaceuticals, in partnership with Janssen and other sector leaders. Rutgers Discovery Informatics Institute recently installed one of the nation’s most powerful supercomputers, Caliburn, which will be available for use by industry.
A world-renowned research university, Princeton University advances the frontiers of human knowledge through its pioneering life sciences research. Its Chemistry, Chemical and Biological Engineering, Molecular Biology, Psychology, and Ecology & Evolutionary Biology academic departments drive that progress. The University also houses several institutes and centers involved with life sciences, including: the Princeton Neuroscience Institute and Lewis-Sigler Institute for Integrative Genomics.
Princeton’s sponsored research approximately a quarter of $1 billion of the sponsored research funding annually. Grants from government agencies comprise the lion’s share of sponsored research funding. However, the University also has ongoing relationships with a number of corporations and foundations that support highly-specialized research.
It’s well known that the University has an international reputation for academic excellence, ranking #1 on U.S. News and World Reports’ Best Colleges list for 5 consecutive years. It has been a member of the prestigious Association of American Universities since 1900.
Rowan University is a public research university and one of only 2 universities in the country with both allopathic and osteopathic medical schools.
The University also partners with industry to deliver advanced science, and access to value-driven patent claims and to patients through effective clinical trials management. Through this holistic approach to commercialization, Rowan University creates unique collaborations with industry to develop value-driven solutions to complex industry healthcare challenges.
Rowan promotes the interests of industry partners through its Office of Technology Commercialization (OTC), dedicated to the commercialization of Rowan research and patent assets, with a particular emphasis on applications in geriatric medicine.
The University is a national leader in geriatric medicine, which is reflected in its world-class research, industry collaborations and technology licenses. It also leads the way in geriatric healthcare through its widely recognized New Jersey Institute for Successful Aging (NJISA). Further, the Rowan Office of Clinical Trials Management allows the University to work with industry partners to help navigate the FDA pathway to market.
New Jersey Institute of Technology (NJIT)
One of the nation’s leading public polytechnic universities, New Jersey Institute of Technology (NJIT) is a top-tier research university that focuses on the science, technology, engineering and mathematics (STEM) disciplines. It has over 25 dedicated outreach centers and laboratories, covering stem cell, brain injury and tissue engineering, to robotics and cybersecurity. In 2016, the University’s research expenditures totaled more than $121 million.
For over 100 years, economic development has been a mainstay of NJIT. Launched in 2014 as an NJIT corporation, the New Jersey Innovation Institute (NJII) became a corporate entity that partners with industry and government to provide innovative and practical solutions for economic development, technical assistance, joint ventures and commercialization of technology. Serving industry-led agendas, NJII is comprised of 5 iLabs including healthcare delivery systems, biotechnology and pharmaceutical production.
The Enterprise Development Center (EDC) is also part of NJII. The EDC is New Jersey’s largest high technology and life science business incubator – and one of the largest in the nation. EDC resident companies have attracted more than $82 million in 3rd-party funding and have generated revenues of $50 million.
Stevens Institute of Technology
Stevens Institute of Technology’s Biotechnology and Drug Discovery Laboratory in the Center for Healthcare Innovation (CHI) is a premiere research and training facility.
CHI partners with Stevens’ faculty, students and external academic and industry collaborators who require the expertise of the laboratory to advance their research. The laboratory explores therapeutic disease targets and identifies model compounds that could be used as structure/activity entry points and scaffold platforms in drug discovery projects.
Faculty, research scientists and associates with extensive experience in biotechnology and drug discovery, operate the facility. They provide industry collaborators with a local academic partner for workforce training. They also serve as a research resource for: protein structure-based and in silico drug screening and discovery; assay development and robotic drug screening; preclinical gene cloning; and, purification of proteins.
The CHI Biotechnology and Drug Discovery Laboratory nurtures entrepreneurship, contributes to maintaining New Jersey as a pharmaceutical and biotechnology hub, and, it positions Stevens as a premier university and industry partner for biotechnology and drug discovery.
Montclair State University
A public research university, Montclair State University delivers the instructional and research resources of a large public university in a supportive, sophisticated and diverse academic environment. The University’s 10 colleges and schools serve over 21,000 undergraduate and graduate students each year, in more than 300 doctoral, master’s, and baccalaureate level programs.
The University’s new Center for Environmental and Life Sciences is devoted to environmental, health and pharmaceutical science research. The Center was designed to foster academic/industry partnerships and collaborations.
With 107,000 square feet, the state-of-the-art Center features classrooms and research labs, expanding the University’s science research infrastructure by 50%. The University’s other institutes and centers include the Sokol Institute for Pharmaceutical Life Sciences and the Center for Quantitative Obesity Research.